Seelos Therapeutics to Host Research and Development Update Conference Call and Webcast on December 15, 2022
NEW YORK, November 23, 2022 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders and rare diseases, today announced that it will hold a Research and Development Update Conference Call and Webcast on Thursday, December 15e of 1-3 p.m. ET. “As we approach...
Read More